Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

First 30 results

April 28, 2026
Taiho Pharmaceutical

U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
April 28, 2026
Taiho Pharmaceutical

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development
April 23, 2026
Otsuka Medical Devices

Recor Medical's Paradise Ultrasound Renal Denervation System Honored with TAG Award for Cardiovascular Therapeutic Innovation (Link to Recor website)
April 21, 2026
Otsuka Pharmaceutical

Efficacy of Lactic Acid Bacterium ONRICb0240 Against Gingivitis Confirmed A collaborative study with the Institute of Science Tokyo brings new hope for oral care
April 21, 2026
Taiho Pharmaceutical

Update on the Phase 3 STAR-121 Study of Anti-TIGIT Antibody Domvanalimab and Anti-PD-1 Antibody Zimberelimab in Non-Small Cell Lung Cancer
April 20, 2026
Otsuka Foods

Otsuka Foods to Revise Prices of Some Products New Prices to Take Effect with Deliveries as of June 1, 2026
April 17, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Receives Judges’ Special Award at MAFF’s 10th Shokuiku Activity Awards “MoguMogu Town” App Recognized for Promoting Food and Nutrition Education
April 1, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Recognized as a “Food and Nutrition Education Practice Excellent Corporation 2026” by the MAFF Leveraging Proprietary Expertise and Services to Promote Health through Nutrition
April 1, 2026
Otsuka Holdings

Otsuka Holdings Certified by the Ministry of Agriculture, Forestry and Fisheries as a “Food and Nutrition Education Practice Excellent Corporation 2026” Promoting Health by Leveraging the Group’s Expertise, Products, and Services
March 27, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Transcend Therapeutics - Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend’s portfolio, including the TSND-201 program for post-traumatic stress disorder (PTSD) -
March 27, 2026
Otsuka Holdings

Otsuka Holdings appoints Board Members and Auditors and Supervisory Board Members
March 27, 2026
Otsuka Pharmaceutical

Otsuka Submits Application in Japan for Iclusig® for First-Line Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
March 25, 2026
Otsuka Holdings

OTSUKA Health Comic Library II Publication of “Water Is Amazing!: The Health of People and the Planet and the Power of Water” Donated to All Elementary Schools Throughout Japan
March 13, 2026
Otsuka Pharmaceutical

Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting
March 11, 2026
Otsuka Pharmaceutical

Launch of Joint Sales of the QuickNavi™-Campylobacter Antigen Diagnostic Kit in Japan
March 9, 2026
Otsuka Pharmaceutical

New and Improved Calorie Mate JELLY Enhanced Taste and Balanced Nutrition, Now Even More Accessible
March 4, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Named Tokyo Sports Promotion Model Company (Sports Practice Category) Employee and Communities Health Initiatives Recognized
March 3, 2026
Otsuka Pharmaceutical

New Release: SOYJOY Azuki & Hojicha A Deep Japanese Flavor with Gentle Sweetness and a Roasted Aroma
March 2, 2026
Otsuka PharmaceuticalOtsuka Medical Devices

Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and Commercially Available in Japan
February 25, 2026
Otsuka Pharmaceutical

New Product Release: /zeroz - a self conditioning food that supports the body’s natural abilities and contains plant-derived kaempferol to help make more effective use of oxygen
February 25, 2026
Otsuka Holdings

Otsuka Group to Enter a Long‑term Agreement to Procure Renewable Electricity from Newly Constructed Solar Power Generation Facilities through JERA Cross — Expanding the Use of “Self‑generated Renewable Energy” to Promote Carbon Neutrality Initiatives—
February 19, 2026
Otsuka Pharmaceutical

Otsuka to Sponsor TOKYO MARATHON 2026 Supporting Runners from Around the World Under the Theme “Believe in People’s Potential.”
February 17, 2026
Otsuka Foods

Otsuka Foods to Launch Two New “My Size” Products: 100kcal My Size Chicken Curry 100kcal My Size Gapao Supporting Healthy Eating Habits with Expanded Selection In Stores across Japan from March 2, 2026
February 17, 2026
Otsuka Foods

Otsuka Foods to Launch Five Main Dip Series Marinades Freezer-Marinating for Delicious Meat Dishes Stocking Frozen Meats in Marinade Takes Stress Out of Cooking
February 13, 2026
Otsuka Pharmaceutical

REXULTI® Listed in the “Essential Medicines List for the Ultra-Acute Phase of Disasters” by the Japanese Association for Disaster Medicine
February 12, 2026
Otsuka Pharmaceutical

Opening Egypt’s First ORONAMIN C DRINK Factory Meeting Growing Demand and Contributing to Community Health
February 9, 2026
Otsuka Foods

Otsuka Foods to Release “Health-Conscious Bon Curry with Full Serving of Japan-Grown Vegetables” Single Box Addresses Multiple Dietary Concerns Also Serves as Emergency Food That Does Not Require Heating Free of 28 Allergens, Gluten-Free, and Made Without Animal-Based Ingredients
February 9, 2026
Otsuka Foods

Otsuka Foods to Release “Bon Curry NEO Smoky Beef Curry: Hot” Deep, Sophisticated Flavor Combines Roasted Spices and Rich Sauce In Stores across Japan from March 2, 2026
February 6, 2026
Otsuka Pharmaceutical

Otsuka Enters into Agreement with South Korea-based Sky Labs for Exclusive Commercialization Rights in Japan to the Automated Blood Pressure Monitor CART BP pro -First-in-world ring type blood pressure monitor that has received regulatory approval and insurance reimbursement in South Korea-
February 5, 2026
Otsuka Pharmaceutical

Tianjin Otsuka Beverage Opens New POCARI SWEAT Factory New facility to serve as a “health awareness hub”